6VW-16327-36385 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-05-17
Dose 1 — Pfizer-BioNTech
2022-06-07
Dose 2 — Pfizer-BioNTech
2022-06-23
Registered in v-safe
2022-06-23
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-06-28
Survey response — day 21, dose 2, dependent
MedDRA: Cough, Rhinorrhoea — Feeling: Fair

Free text: Cough, runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-07-05
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-07-12
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-07-19
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-09-08
Survey response — 3 months, dose 2, dependent
MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough, runny nose, fever

MedDRA releases: 2024-11 · check-in free text available
2022-12-08
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-05-17	Pfizer-BioNTech	No
2	2022-06-07	Pfizer-BioNTech	No

Free text

Release 12 — day 21, dose 2, dependent

2022-06-28

Symptoms: Cough, runny nose

Release 12 — 3 months, dose 2, dependent

2022-09-08

Symptoms: Cough, runny nose, fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release